Dielectric Tissue Imaging in Cavotricuspid Isthmus Ablation — ERUCA  

Atrial Fibrillation and Flutter Clinical Trial

Official title: Dielectric Tissue Imaging in Cavotricuspid Isthmus Ablation

Status Recruiting

Clinical Trial Summary

This is a prospective, single center, non-randomized, open-label, single arm study in which we will gather data and physician input for the assessment and further development of the KODEX - EPD functions for assessing tissue pressure, tissue thickness, lesion transmurality.

Clinical Trial Description

This is a prospective, single center, non-randomized, open-label, single arm study in which we will gather data and physician input for the assessment and further development of the KODEX - EPD functions for assessing tissue pressure, tissue thickness, lesion transmurality. The study will include up to 30 subjects. We will enroll patients with atrial flutter and patients with atrial fibrillation who are scheduled to undergo RF ablation of the cavotricuspid isthmus (CTI). Both male and female subjects who meet all eligibility criteria and give written informed consent will be enrolled in the study. We will be assessing the feasibility of the KODEX-EPD tissue pressure (TP), tissue thickness and lesion transmurality applications. ;

Related Conditions & MeSH terms

• Atrial Fibrillation
• Atrial Fibrillation and Flutter

• NCT number: NCT04438395
• Study type: Observational
• Source: EPD Solutions, A Philips Company
• Contact: Anneleen Viville
• Phone: +32479983495
• Email: Anneleen.Viville@philips.com
• Status: Recruiting
• Start date: July 20, 2020
• Completion date: June 30, 2022